Arthritis Research UK is the resource for anyone looking for the latest news in the fight against arthritis. We’re providing answers today and tomorrow toward a future free from arthritis.
A maximum of 200 results have been returned
A new study has highlighted the high treatment persistence rates associated with denosumab among osteoporosis patients, thus adding to the effectiveness of the therapy.
Find out more
A team from Queen Mary University of London have been able to develop antibodies that are specific to damaged arthritic cartilage, meaning they could avoid the side effects associated with other arthritis therapies.
The positive impact of calcium supplements on bone mineral density among older men is not generally sustained in any substantial way once supplementation is ceased, according to a new study from New Zealand.
Two international studies led by the University of Malaya have outlined the development of new technology to enable the creation of biomedical implants with the ability to accelerate bone healing in a personalised manner.
The rheumatoid arthritis drug market will grow significantly in the next ten years, according to new research.
A new drug called odanacatib has been shown to significantly reduce the risk of osteoporotic hip, spine and non-vertebral fractures in a clinical trial.
A new study carried out in Newcastle has suggested that osteoporosis could be going under-diagnosed and under-treated among people over the age of 85.
Cartilage has been found to play an active role in the destruction and remodeling of joints seen in rheumatoid arthritis, according to researchers from Australia.
Mortality rates following joint replacements or hip fracture treatment have fallen over the last ten years, according to two new reports.
Smokers who consume too much sodium are at an elevated risk of developing rheumatoid arthritis, according to new research from Sweden.